258 related articles for article (PubMed ID: 18851906)
41. Predictors of poor adherence to medication among patients with first-episode schizophrenia-spectrum disorder.
Quach PL; Mors O; Christensen TØ; Krarup G; Jørgensen P; Bertelsen M; Jeppesen P; Petersen L; Thorup A; Nordentoft M
Early Interv Psychiatry; 2009 Feb; 3(1):66-74. PubMed ID: 21352177
[TBL] [Abstract][Full Text] [Related]
42. Relationships among medication adherence, insight, and neurocognition in chronic schizophrenia.
Na E; Yim SJ; Lee JN; Kim JM; Hong K; Hong MH; Han H
Psychiatry Clin Neurosci; 2015 May; 69(5):298-304. PubMed ID: 25600955
[TBL] [Abstract][Full Text] [Related]
43. Adherence and nonadherence to antipsychotic medications.
Kozuki Y; Schepp KG
Issues Ment Health Nurs; 2005 May; 26(4):379-96. PubMed ID: 16020055
[TBL] [Abstract][Full Text] [Related]
44. Subjective assessments of the quality of life, well-being and self-efficacy in patients with schizophrenia.
Chino B; Nemoto T; Fujii C; Mizuno M
Psychiatry Clin Neurosci; 2009 Aug; 63(4):521-8. PubMed ID: 19531107
[TBL] [Abstract][Full Text] [Related]
45. Psychiatric genetic counseling for serious mental illness: Impact on psychopathology and psychotropic medication adherence.
Morris E; Batallones R; Ryan J; Slomp C; Carrion P; Albert A; Austin J
Psychiatry Res; 2021 Feb; 296():113663. PubMed ID: 33360966
[TBL] [Abstract][Full Text] [Related]
46. An excitement subscale of the Positive and Negative Syndrome Scale.
Lindenmayer JP; Brown E; Baker RW; Schuh LM; Shao L; Tohen M; Ahmed S; Stauffer VL
Schizophr Res; 2004 Jun; 68(2-3):331-7. PubMed ID: 15099614
[TBL] [Abstract][Full Text] [Related]
47. The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
Byerly MJ; Nakonezny PA; Rush AJ
Schizophr Res; 2008 Mar; 100(1-3):60-9. PubMed ID: 18255269
[TBL] [Abstract][Full Text] [Related]
48. Mediating role of illness representation among social support, therapeutic alliance, experience of medication side effects, and medication adherence in persons with schizophrenia.
Rungruangsiripan M; Sitthimongkol Y; Maneesriwongul W; Talley S; Vorapongsathorn T
Arch Psychiatr Nurs; 2011 Aug; 25(4):269-83. PubMed ID: 21784285
[TBL] [Abstract][Full Text] [Related]
49. Denial and acceptance coping styles and medication adherence in schizophrenia.
Aldebot S; de Mamani AG
J Nerv Ment Dis; 2009 Aug; 197(8):580-4. PubMed ID: 19684494
[TBL] [Abstract][Full Text] [Related]
50. The structure of Antonovsky's sense of coherence in patients with schizophrenia and its relationship to psychopathology.
Bengtsson-Tops A; Brunt D; Rask M
Scand J Caring Sci; 2005 Sep; 19(3):280-7. PubMed ID: 16101857
[TBL] [Abstract][Full Text] [Related]
51. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
[TBL] [Abstract][Full Text] [Related]
52. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
[TBL] [Abstract][Full Text] [Related]
53. Adherence to medication and quality of life in people with schizophrenia: results of a European multicenter study.
Puschner B; Born A; Giessler A; Helm H; Leese M; Bindman JP; Gray RJ; Schene A; Kikkert M; Burti L; Marrella G; Becker T
J Nerv Ment Dis; 2006 Oct; 194(10):746-52. PubMed ID: 17041286
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
[TBL] [Abstract][Full Text] [Related]
55. Risk profiles for non-adherence to antipsychotic medications.
McCann TV; Boardman G; Clark E; Lu S
J Psychiatr Ment Health Nurs; 2008 Oct; 15(8):622-9. PubMed ID: 18803735
[TBL] [Abstract][Full Text] [Related]
56. Homeless women with schizophrenia reported lower adherence to their medication than men: results from the French Housing First experience.
Tinland A; Zemmour K; Auquier P; Boucekine M; Girard V; Loubière S; Fond G; Boyer L;
Soc Psychiatry Psychiatr Epidemiol; 2017 Sep; 52(9):1113-1122. PubMed ID: 28656452
[TBL] [Abstract][Full Text] [Related]
57. Qualitative inquiry into motivators for maintaining medication adherence among Taiwanese with schizophrenia.
Chang YT; Tao SG; Lu CL
Int J Ment Health Nurs; 2013 Jun; 22(3):272-8. PubMed ID: 22882876
[TBL] [Abstract][Full Text] [Related]
58. The influence of adherence to antipsychotics medication on the quality of life among patients with schizophrenia in Indonesia.
Endriyani L; Chien CH; Huang XY; Chieh-Yu L
Perspect Psychiatr Care; 2019 Apr; 55(2):147-152. PubMed ID: 29578605
[TBL] [Abstract][Full Text] [Related]
59. Association between functional recovery and medication adherence in schizophrenia.
Ishii J; Kodaka F; Miyata H; Yamadera W; Seto H; Higuchi H; Tsuruoka Y; Shigeta M
Neuropsychopharmacol Rep; 2022 Dec; 42(4):510-515. PubMed ID: 36196584
[TBL] [Abstract][Full Text] [Related]
60. Adherence predicts symptomatic and psychosocial remission in schizophrenia: Naturalistic study of patient integration in the community.
Bernardo M; Cañas F; Herrera B; García Dorado M
Rev Psiquiatr Salud Ment; 2017; 10(3):149-159. PubMed ID: 27291833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
